Mark Andrew Wilson, SVP & General Counsel at NEKTAR THERAPEUTICS (NKTR), sold 16,032 shares at $19.45 ($255K) on 2021-02-03, disclosed to the SEC on 2021-02-04.
Open-market sale of $255k NKTR by SVP & General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.80 | 5,344 | $47K | 18.4% |
| 2 | $19.45 | 5,344 | $104K | 40.8% |
| 3 | $19.45 | 5,344 | $104K | 40.8% |
| Total | $15.90 avg | 16,032 | $255K | 100% |
| Filing → |
| NKTR | SELL | 2025-05-21 | $7K | — | Filing → |
| NKTR | SELL | 2025-02-21 | $11K | — | Filing → |
| NKTR | SELL | 2024-12-26 | $45K | — | Filing → |